Vitexicarpin effects proliferation and apoptosis in mutated p53 breast cancer cell

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Objective: To elucidate the effect of proliferation and apoptosis induced by vitexicarpin in mutated p53 Hs578T cell line and study the expression of c-Myc, p21 and Bcl-2 protein in Hs578T and wild p53 MCF-7 cell pre-treated with vitexicarpin. Methods: Cells were treated with various concentrations of vitexicarpin (0, 0.1, 0.2, 0.5, 1.0 μmol/L). MTT assays were used to detect cell proliferation at different time points with different doses of vitexicarpin. TUNEL assays were performed to examine apoptosis in cells pretreated with vitexicarpin. The authors detected three main proteins involved in apoptosis; c-Myc, bcl-2 and p21 protein in various concentrations of vitexicarpin-treated cells. To understand the function of c-Myc protein in the effect of vitexicarpin, the authors transiently transfected c-Myc protein in Hs578T cell and detected the cellular effect of vitexicarpin. Results: Proliferation of Hs578T and MCF-7 cells were inhibited markedly by vitexicarpin at concentrations above 0.2 μmol/L (IC50=0.25 μmol/L and 0.53 p, mol/L at 72 h respectively). TUNEL assays revealed that the rates of TUNEL positive cells were 10.15%, 27.33% and 35.34% when exposing Hs578T cells to 0.1, 0.2 and 0.5 μmol/L of vitexicarpin respectively. In control cells, the rates of TUNEL positive cells were 4.65%. Cells pretreated with higher concentrations of vitexicarpin expressed less c-Myc and Bcl-2 in Hs578T cells. In contrast, p21 decreased when cells were treated with the same conditions. When c-Myc transient transfection was performed in vitexicarpin-treated cells, the effect of p21 and Bcl-2 disappeared. The proliferative function of vitexicarpin declined in Hs578T/c-Myc cells. When treated with 0.5 μmol/L vitexicarpin, A value increased 1.53 times at 72 h. Conversely, A value decreased 48% at the same condition in MCF-7/c-Myc cells. Conclusion: The suppressing mechanism of vitexicarpin for malignant tumors is through c-Myc in p53 mutated Hs578T cells. And it is multi-directional and varies in different cells.

Original languageEnglish
Pages (from-to)703-707
Number of pages5
JournalNational Medical Journal of China
Volume90
Issue number10
DOIs
StatePublished - 16 Mar 2010

Keywords

  • Apoptosis
  • Breast neoplasms
  • C-Myc protein
  • Genes, p53
  • Vitexicarpin

Fingerprint

Dive into the research topics of 'Vitexicarpin effects proliferation and apoptosis in mutated p53 breast cancer cell'. Together they form a unique fingerprint.

Cite this